Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)

China · Delayed Price · Currency is CNY

68.28

-0.95 (-1.37%)

Feb 13, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Infectious Diseases	366.31M
Infectious Diseases Growth	33.07%
Drug and Substance Abuse	231.69M
Drug and Substance Abuse Growth	13.70%
Women's Health	76.39M
Women's Health Growth	7.72%
COVID-19 Testing	57.19M
COVID-19 Testing Growth	-35.76%
Tumor	32.67M
Tumor Growth	64.16%
Cardiac Muscle	13.85M
Cardiac Muscle Growth	3.26%
Other Business	4.22M
Other Business Growth	72.71%
Other	84.27M
Other Growth	5.42%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Foreign	819.10M
Foreign Growth	17.94%
China	43.27M
China Growth	-25.07%